LYL797

· Lyell Immunopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYL797, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate LYL797 in Adults With Solid Tumors [Phase 1]